The Pacific Northwest Prostate Cancer SPORE, one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort of four institutions working together toward a common goal of reducing morbidity and mortality associated with prostate cancer. This work begins with gaining a better understanding of this disease. Understanding how and why prostate cancer can turn deadly is key to developing therapies that may effectively treat men with recurrent or advanced prostate cancer, for which there is no cure. This 5-year grant was originally awarded in 2002, and has been competitively renewed three times, most recently in 2018. Its longevity speaks to the innovative and groundbreaking progress achieved by this team.
The overall goal of the Patient Advocacy Committee of the Pacific Northwest Prostate Cancer SPORE is to convey patient opinion and feedback to investigators in order to promote and hasten research aimed at the diagnosis, prognosis, treatment and ultimately the prevention of prostate cancer.